0.41
0.41 (0%)
As of Feb 14, 2025
Spruce Biosciences, Inc. [SPRB]
Source:
Company Overview
Spruce Biosciences, Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need.
| Country | United States |
| Headquarters | south san francisco, california |
| Phone Number | ( 415 ) 655-4168 |
| Industry | manufacturing |
| CEO | Javier Szwarcberg, M.D., Mph |
| Website | www.sprucebiosciences.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0.6 |
| Operating Profit | $-9.4 |
| Net Income | $-8.7 |
| Net Cash | $-36.3 |
Profit Ratios
| Gross Margin | $0.6 |
| Operating Margin | -1,562.8 |
| Profit as % of Revenues | -6.9% |
| Profit as % of Assets | -26.4% |
| Profit as % of Stockholder Equity | -16.8% |
Management Effectiveness
| Return on Equity | -16.8% |
| Return on Assets | -13.3% |
| Turnover Ratio | 1.8% |
| EBITA | $-9.4 |
Balance Sheet and Cash Flow Measures
| Total Assets | $65.1 |
| Total Liabilities | $13.5 |
| Operating Cash Flow | $-35.3 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $-1 |
